- Home
- ROIV vs CSWI Comparison
ROIV vs CSWI Comparison
Compare ROIV & CSWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CSWI
- Stock Information
- Founded
- ROIV 2014
- CSWI 2014
- Country
- ROIV United Kingdom
- CSWI United States
- Employees
- ROIV N/A
- CSWI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CSWI Home Furnishings
- Sector
- ROIV Health Care
- CSWI Industrials
- Exchange
- ROIV Nasdaq
- CSWI Nasdaq
- Market Cap
- ROIV 8.4B
- CSWI 6.7B
- IPO Year
- ROIV N/A
- CSWI N/A
- Fundamental
- Price
- ROIV $11.83
- CSWI $415.66
- Analyst Decision
- ROIV Strong Buy
- CSWI Strong Buy
- Analyst Count
- ROIV 9
- CSWI 1
- Target Price
- ROIV $17.69
- CSWI N/A
- AVG Volume (30 Days)
- ROIV 4.5M
- CSWI 108.3K
- Earning Date
- ROIV 11-12-2024
- CSWI 10-30-2024
- Dividend Yield
- ROIV N/A
- CSWI 0.23%
- EPS Growth
- ROIV N/A
- CSWI 10.71
- EPS
- ROIV 5.89
- CSWI 7.36
- Revenue
- ROIV $129,128,999.00
- CSWI $839,930,000.00
- Revenue This Year
- ROIV $48.37
- CSWI $12.12
- Revenue Next Year
- ROIV $13.76
- CSWI $6.66
- P/E Ratio
- ROIV $2.01
- CSWI $55.96
- Revenue Growth
- ROIV 145.68
- CSWI 8.55
- 52 Week Low
- ROIV $8.61
- CSWI $172.97
- 52 Week High
- ROIV $13.06
- CSWI $428.47
- Technical
- Relative Strength Index (RSI)
- ROIV 51.97
- CSWI 63.64
- Support Level
- ROIV $11.05
- CSWI $402.02
- Resistance Level
- ROIV $12.05
- CSWI $428.47
- Average True Range (ATR)
- ROIV 0.30
- CSWI 10.76
- MACD
- ROIV -0.02
- CSWI 0.63
- Stochastic Oscillator
- ROIV 61.86
- CSWI 81.88
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CSWI CSW Industrials Inc.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.